Pages that link to "Q37138843"
Jump to navigation
Jump to search
The following pages link to Baseline characteristics of the randomised cohort from the Look AHEAD (Action for Health in Diabetes) study (Q37138843):
Displaying 50 items.
- Multiple risk factor interventions for primary prevention of coronary heart disease (Q24234642) (← links)
- Aging and physical function in type 2 diabetes: 8 years of an intensive lifestyle intervention (Q27301778) (← links)
- Prospective association of a genetic risk score and lifestyle intervention with cardiovascular morbidity and mortality among individuals with type 2 diabetes: the Look AHEAD randomised controlled trial (Q27325816) (← links)
- Effect of an intensive lifestyle intervention on atrial fibrillation risk in individuals with type 2 diabetes: the Look AHEAD randomized trial (Q27334353) (← links)
- Effect of the look AHEAD study intervention on medication use and related cost to treat cardiovascular disease risk factors in individuals with type 2 diabetes (Q30494654) (← links)
- Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial (Q30499944) (← links)
- Cardiovascular disease risk factors, depression symptoms and antidepressant medicine use in the Look AHEAD (Action for Health in Diabetes) clinical trial of weight loss in diabetes (Q30500360) (← links)
- Obesity susceptibility loci and dietary intake in the Look AHEAD Trial (Q30514020) (← links)
- FTO predicts weight regain in the Look AHEAD clinical trial (Q30543330) (← links)
- Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes (Q30548796) (← links)
- Genetic modifiers of cardiorespiratory fitness response to lifestyle intervention (Q30580579) (← links)
- Associations of sleep disturbance and duration with metabolic risk factors in obese persons with type 2 diabetes: data from the Sleep AHEAD Study (Q30620034) (← links)
- Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of the Look AHEAD randomised clinical trial (Q30651606) (← links)
- Genetic Predictors of Depressive Symptoms in the Look AHEAD Trial (Q30676637) (← links)
- Genetic Predisposition to Weight Loss and Regain With Lifestyle Intervention: Analyses From the Diabetes Prevention Program and the Look AHEAD Randomized Controlled Trials (Q30681813) (← links)
- Prevalence and predictors of abnormal cardiovascular responses to exercise testing among individuals with type 2 diabetes: the Look AHEAD (Action for Health in Diabetes) study (Q33751603) (← links)
- Do genetic modifiers of high-density lipoprotein cholesterol and triglyceride levels also modify their response to a lifestyle intervention in the setting of obesity and type-2 diabetes mellitus?: The Action for Health in Diabetes (Look AHEAD) study (Q33829225) (← links)
- A randomized study on the effect of weight loss on obstructive sleep apnea among obese patients with type 2 diabetes: the Sleep AHEAD study (Q33888204) (← links)
- ANGPTL4 variants E40K and T266M are associated with lower fasting triglyceride levels in Non-Hispanic White Americans from the Look AHEAD Clinical Trial (Q33946007) (← links)
- Neighborhood socioeconomic status, depression, and health status in the Look AHEAD (Action for Health in Diabetes) study (Q34105670) (← links)
- Recruitment of young adults into a randomized controlled trial of weight gain prevention: message development, methods, and cost (Q34116478) (← links)
- A 1-year lifestyle intervention for weight loss in individuals with type 2 diabetes reduces high C-reactive protein levels and identifies metabolic predictors of change: from the Look AHEAD (Action for Health in Diabetes) study (Q34237273) (← links)
- Sleep architecture following a weight loss intervention in overweight and obese patients with obstructive sleep apnea and type 2 diabetes: relationship to apnea-hypopnea index (Q34474548) (← links)
- Implications of Look AHEAD for clinical trials and clinical practice (Q34490483) (← links)
- Fiber intake and plasminogen activator inhibitor-1 in type 2 diabetes: Look AHEAD (Action for Health in Diabetes) trial findings at baseline and year 1. (Q34617416) (← links)
- Human cardiovascular disease IBC chip-wide association with weight loss and weight regain in the look AHEAD trial (Q34641723) (← links)
- Body image changes associated with participation in an intensive lifestyle weight loss intervention (Q35007482) (← links)
- Metabolic factors, adipose tissue, and plasminogen activator inhibitor-1 levels in type 2 diabetes: findings from the look AHEAD study (Q35088730) (← links)
- The Look AHEAD Trial: A Review and Discussion Of Its Outcomes (Q35116229) (← links)
- A novel multidisciplinary intervention for long-term weight loss and glycaemic control in obese patients with diabetes (Q35534520) (← links)
- Effects of weight loss intervention on erectile function in older men with type 2 diabetes in the Look AHEAD trial (Q35702929) (← links)
- The Look AHEAD Trial: Implications for Lifestyle Intervention in Type 2 Diabetes Mellitus (Q35849463) (← links)
- Systolic Blood Pressure Control Among Individuals With Type 2 Diabetes: A Comparative Effectiveness Analysis of Three Interventions (Q35862979) (← links)
- Lifestyle change and mobility in obese adults with type 2 diabetes (Q35919090) (← links)
- Association of type 2 diabetes susceptibility loci with one-year weight loss in the look AHEAD clinical trial (Q36120556) (← links)
- Effect of 1 year of an intentional weight loss intervention on bone mineral density in type 2 diabetes: results from the Look AHEAD randomized trial (Q36133698) (← links)
- The relationship between obstructive sleep apnea and self-reported stroke or coronary heart disease in overweight and obese adults with type 2 diabetes mellitus (Q36147100) (← links)
- Graded Resistance Exercise And Type 2 Diabetes in Older adults (The GREAT2DO study): methods and baseline cohort characteristics of a randomized controlled trial. (Q36266972) (← links)
- Adiponectin and the mediation of HDL-cholesterol change with improved lifestyle: the Look AHEAD Study (Q36387179) (← links)
- Prospective Association of GLUL rs10911021 With Cardiovascular Morbidity and Mortality Among Individuals With Type 2 Diabetes: The Look AHEAD Study (Q36392873) (← links)
- Impact of the look AHEAD intervention on NT-pro brain natriuretic peptide in overweight and obese adults with diabetes (Q36433506) (← links)
- Changes in body composition over 8 years in a randomized trial of a lifestyle intervention: the look AHEAD study (Q36450113) (← links)
- The Effect of Changes in Cardiorespiratory Fitness and Weight on Obstructive Sleep Apnea Severity in Overweight Adults with Type 2 Diabetes (Q36461044) (← links)
- Plasma concentrations of trans fatty acids in persons with type 2 diabetes between September 2002 and April 2004. (Q36714709) (← links)
- Long-term effect of weight loss on obstructive sleep apnea severity in obese patients with type 2 diabetes (Q36761257) (← links)
- Four-year analysis of cardiovascular disease risk factors, depression symptoms, and antidepressant medicine use in the Look AHEAD (Action for Health in Diabetes) clinical trial of weight loss in diabetes (Q36782608) (← links)
- Patterns of weight change associated with long-term weight change and cardiovascular disease risk factors in the Look AHEAD Study (Q36784472) (← links)
- Severe hypoglycemia in the Look AHEAD Trial (Q37018414) (← links)
- Erectile dysfunction in type 2 diabetic men: relationship to exercise fitness and cardiovascular risk factors in the Look AHEAD trial (Q37109366) (← links)
- Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial (Q37151277) (← links)